Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 82Lymphoid 61Tumor-Agnostic 27Gastrointestinal 27Plasma cell 22Breast 17Myeloid 15Thoracic 14Gynecologic 4Dermatologic 4Sarcoma 3Head & Neck 3Classical hematology 3CNS 3Genitourinary 2NET 1Endocrine 1

Conditions

Brain Neoplasms 1702Glioblastoma 1308Glioma 995Neuroblastoma 408Central Nervous System Neoplasms 384Astrocytoma 384Gliosarcoma 286Oligodendroglioma 238Neoplasms 226Breast Neoplasms 216Meningioma 179Medulloblastoma 172Carcinoma, Non-Small-Cell Lung 149Recurrence 147Neoplasm Metastasis 138Lung Neoplasms 138Ependymoma 128Melanoma 119Sarcoma 117Neurofibromatosis 1 110Meningeal Carcinomatosis 107Lymphoma 95Neuroma, Acoustic 82Diffuse Intrinsic Pontine Glioma 81Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Head and Neck Neoplasms 79Ovarian Neoplasms 73Lymphoma, Follicular 73Pheochromocytoma 71Paraganglioma 68

Interventions

thymoglobulin 1sargramostim 1fludarabine 1dinutuximab 1Rituximab 1Melphalan 1Levetiracetam 1Isotretinoin 1Interleukin-2 1Granulocyte-Macrophage Colony-Stimulating Factor 1Cyclophosphamide 1Busulfan 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Neoplasm, Residual × CNS × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT02169609 2024-04-22

Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma

Fundació Sant Joan de Déu

Phase 2 Completed
24 enrolled
CNS

Neuroblastoma, Neoplasm, Residual

NCT05850377 2023-05-09

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Sociedad de Lucha Contra el Cáncer del Ecuador

Unknown
90 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡